Home › Therapeutic areas › Neurology › Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral Muscular Dystrophy (2 companies)
Companies with an active program in Facioscapulohumeral Muscular Dystrophy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | MetabolicNeurology Rare | 1 | Phase 3 | 10 |
| SRPT | Sarepta Therapeutics, Inc. | Neurology Rare | 1 | Approved | 10 |
No companies match.